Table 4. Comparison of treatment outcome according to QFT-GIT results in patients with pleural TB.
Variable | Total (n=199) | QFT-GIT-negative group (n=36) | QFT-GIT-positive group (n=163) | P value |
---|---|---|---|---|
Favorable outcome | 163 (81.9%) | 24 (66.7%) | 139 (85.3%) | 0.017 |
Unfavorable outcome | 36 (18.1%) | 12 (33.3%) | 24 (14.7%) | 0.017 |
Discontinuation of anti-TB medication | 6 (3.0%) | 3 (8.3%) | 3 (1.8%) | 0.074 |
Follow-up loss | 17 (8.5%) | 3 (8.3%) | 14 (8.6%) | 1.000 |
Death | 13 (6.5%) | 6 (16.7%) | 7 (4.3%) | 0.015 |
TB-related death | 4 (2.0%) | 1 (2.8%) | 3 (1.8%) | 0.553 |
Not TB-related death | 9 (4.5%) | 5 (13.9%) | 4 (2.5%) | 0.011 |
QFT-GIT, QuantiFERON-TB Gold In-Tube; TB, tuberculosis.